Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safe Implementation of Treatments in Stroke (SITS) - Intravenous Thrombolysis in Acute Ischaemic Stroke Patients Over 80 Years, SITS-IVT>80 Years Study

NCT04260347 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT04260347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04260347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safe Implementation of Treatments in Stroke (SITS) - Intravenous Thrombolysis in Acute Ischaemic Stroke Patients Over 80 Years, SITS-IVT>80 Years Study
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
May 14, 2020
Completion date
December 31, 2022
Enrollment
1,655 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischaemic stroke